bisindolylmaleimide i has been researched along with Neoplasms in 3 studies
bisindolylmaleimide I: a bis(indolyl)maleimide
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Meijer, L | 1 |
| Flajolet, M | 1 |
| Greengard, P | 1 |
| Xia, Z | 1 |
| Knaak, C | 1 |
| Ma, J | 1 |
| Beharry, ZM | 1 |
| McInnes, C | 1 |
| Wang, W | 1 |
| Kraft, AS | 1 |
| Smith, CD | 1 |
| Boyle, GM | 1 |
| D'Souza, MM | 1 |
| Pierce, CJ | 1 |
| Adams, RA | 1 |
| Cantor, AS | 1 |
| Johns, JP | 1 |
| Maslovskaya, L | 1 |
| Gordon, VA | 1 |
| Reddell, PW | 1 |
| Parsons, PG | 1 |
1 review available for bisindolylmaleimide i and Neoplasms
| Article | Year |
|---|---|
Pharmacological inhibitors of glycogen synthase kinase 3.
Topics: Animals; Cell Differentiation; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Glycogen Synthase Kinas | 2004 |
2 other studies available for bisindolylmaleimide i and Neoplasms
| Article | Year |
|---|---|
Synthesis and evaluation of novel inhibitors of Pim-1 and Pim-2 protein kinases.
Topics: Animals; Antineoplastic Agents; Cell Line; Cell-Free System; Combinatorial Chemistry Techniques; Fem | 2009 |
Intra-lesional injection of the novel PKC activator EBC-46 rapidly ablates tumors in mouse models.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Diterpenes; Heterografts; Humans; Indoles; Injecti | 2014 |